Emerging therapies in relapsed and refractory peripheral T-cell lymphoma.
In this report, we discuss emerging new therapies in relapsed and refractory PTCL and try to place these new findings in the evolving biological understanding of the disease.
PMID: 27058850 [PubMed - as supplied by publisher]
Source: Clinical Advances in Hematology and Oncology - Category: Cancer & Oncology Tags: Clin Adv Hematol Oncol Source Type: research
More News: Biology | Cancer & Oncology | Food and Drug Administration (FDA) | Genetics | Hematology | Hodgkin's Disease | Lymphoma | Molecular Biology | Study | T-cell Lymphoma